0 (0%) | 10-15 12:16 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 21.64 ![]() |
1-year : | 22.41 ![]() |
Resists | First : | 18.53 ![]() |
Second : | 19.19 ![]() |
Pivot price | 18.11 ![]() |
|||
Supports | First : | 17.46 | Second : | 14.53 |
MAs | MA(5) : | 17.66 ![]() |
MA(20) : | 18.25 ![]() |
MA(100) : | 18.41 ![]() |
MA(250) : | 17.89 ![]() |
|
MACD | MACD : | -0.4 ![]() |
Signal : | -0.3 ![]() |
%K %D | K(14,3) : | 7.5 ![]() |
D(3) : | 7.2 ![]() |
RSI | RSI(14): 30.7 ![]() |
|||
52-week | High : | 20.03 | Low : | 15.6 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ SBRA ] has closed above bottom band by 16.2%. Bollinger Bands are 62.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 17.77 - 17.89 | 17.89 - 18 |
Low: | 17.24 - 17.39 | 17.39 - 17.53 |
Close: | 17.4 - 17.63 | 17.63 - 17.85 |
Tue, 14 Oct 2025
What to expect from SBRA in the next 30 days - July 2025 Decliners & Capital Efficient Trade Techniques - newser.com
Mon, 13 Oct 2025
Sector ETF performance correlation with SBRA - Weekly Trend Recap & Daily Profit Maximizing Trade Tips - newser.com
Sat, 11 Oct 2025
Sabra Health Care: SHOP Model As A Value Catalyst (NASDAQ:SBRA) - Seeking Alpha
Mon, 06 Oct 2025
Sabra Health Care REIT, Inc. to Attend the AHCA/NCAL Convention & Expo - Business Wire
Thu, 02 Oct 2025
Sabra Healthcare REIT (NASDAQ:SBRA) Coverage Initiated at Cantor Fitzgerald - MarketBeat
Wed, 01 Oct 2025
New Analyst Forecast: $SBRA Given $20.0 Price Target - Quiver Quantitative
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 240 (M) |
Shares Float | 236 (M) |
Held by Insiders | 1.2 (%) |
Held by Institutions | 101.2 (%) |
Shares Short | 15,480 (K) |
Shares Short P.Month | 19,340 (K) |
EPS | 0.75 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 11.31 |
Profit Margin | 24.8 % |
Operating Margin | 38.4 % |
Return on Assets (ttm) | 3.2 % |
Return on Equity (ttm) | 6.6 % |
Qtrly Rev. Growth | 7.8 % |
Gross Profit (p.s.) | 2.06 |
Sales Per Share | 3.06 |
EBITDA (p.s.) | 1.83 |
Qtrly Earnings Growth | 170 % |
Operating Cash Flow | 339 (M) |
Levered Free Cash Flow | 287 (M) |
PE Ratio | 23.09 |
PEG Ratio | 0 |
Price to Book value | 1.55 |
Price to Sales | 5.73 |
Price to Cash Flow | 12.42 |
Dividend | 0.3 |
Forward Dividend | 0 |
Dividend Yield | 1.7% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |